In the original manuscript, author N. Islam had the wrong affiliation. It should have been University of Massachusetts Medical Center, Worcester, USA.
The corrected author list is below.
The authors apologize for the error.
. 2014 Jul;25(7):1449. doi: 10.1093/annonc/mdu179
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma
A M Evens
1, K R Carson
2, J Kolesar
3, C Nabhan
4, I Helenowski
5, N Islam
5, B Jovanovic
6, P M Barr
7, P F Caimi
8, S A Gregory
9, L I Gordon
10
K R Carson
2Division of Hematology/Oncology, Washington University School of Medicine, St. Louis
Find articles by K R Carson
J Kolesar
3School of Pharmacy, University of Wisconsin Carbone Cancer Center, Madison
Find articles by J Kolesar
C Nabhan
4Medicine, Division of Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge
Find articles by C Nabhan
B Jovanovic
6Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago
Find articles by B Jovanovic
P M Barr
7Division of Hematology/Oncology, University of Rochester Medical Center, Rochester
Find articles by P M Barr
P F Caimi
8Hematology and Oncology, University Hospitals Case Medical Center, Cleveland
Find articles by P F Caimi
S A Gregory
9Division of Hematology and Medical Oncology, Rush University Medical Center, Chicago
Find articles by S A Gregory
L I Gordon
10Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA
Find articles by L I Gordon
1Division of Hematology/Oncology, Tufts Medical Center, Boston
2Division of Hematology/Oncology, Washington University School of Medicine, St. Louis
3School of Pharmacy, University of Wisconsin Carbone Cancer Center, Madison
4Medicine, Division of Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge
5University of Massachusetts Medical Center, Worcester
6Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago
7Division of Hematology/Oncology, University of Rochester Medical Center, Rochester
8Hematology and Oncology, University Hospitals Case Medical Center, Cleveland
9Division of Hematology and Medical Oncology, Rush University Medical Center, Chicago
10Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA
© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
PMCID: PMC4351366 PMID: 32018560
This corrects the article "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma" in volume 24 on page 3076.